Latest total assets for IMAB: $210M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total assets for IMAB is $210M as of June 2025. That compares with $250M in the prior-year period — down 18.6% year over year. Investors often review this figure alongside I-Mab's historical trend and sector peers before judging valuation or financial health.
Over the past year, IMAB's total assets moved from $250M to $210M — a 18.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in I-Mab's operating scale or balance-sheet position.
A total assets figure of $210M for IMAB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting IMAB's total assets ($210M), review year-over-year change from $250M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack I-Mab's total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.